Expression of the telomerase catalytic sub-unit (htert) constitutes a key s
tep in the development of human cancer. Although htert regulation is still
unclear, several studies suggest that c-myc may activate its expression. Pr
ostate cancer is one of the most common malignancies among men in Western c
ountries. Since de-regulated expression of myc as well as telomerase activa
tion may contribute to the pathogenicity of this cancer, we investigated th
is pathway in prostate tumorigenesis, For this purpose, myc- and htert-mRNA
expression was quantified in 33 sporadic prostate tumors using a real-time
quantitative PCR assay based on TaqMan methodology. myc over-expression wa
s observed in 19 (58%) of 33 tumors, whereas telomerase status evaluated by
htert expression was observed in 22 (67%), There was no correlation betwee
n myc over-expression or htert expression level and tumor stage or Gleason
grade. A significant association (p = 0.0024) was found between myc over-ex
pression and elevated htert expression, indicating that the up-regulation o
f telomerase activity often observed in prostate tumors might be conferred
through transactivation of htert by myc, It is likely that the ability of c
-myc protein to stimulate expression of htert and thereby enhance telomeras
e activity represents an important step in prostate tumorigenesis. (C) 2000
Wiley-Liss, Inc.